Skip to main content

6 Result(s)

within Yongjie **e Remove this filter Biochemistry, general Remove this filter Medical Law Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Retraction Note: Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate

    Chang Ren, Yao Wang, Mei Zhang, Dexuan Kong, Chen Ning… in Pharmaceutical Research (2023)

    Download PDF (397 KB) View Article

  2. No Access

    Article

    RETRACTED ARTICLE: Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate

    Chang Ren, Yao Wang, Mei Zhang, Dexuan Kong, Chen Ning… in Pharmaceutical Research (2021)

  3. No Access

    Article

    N-acetylcysteine Protects Mice from High Fat Diet-induced Metabolic Disorders

    To study the effects of N-acetylcysteine (NAC, C5H9NO3S) on diet-induced obesity and obesity-related metabolic disorders.

    Yongjie Ma, Mingming Gao, Dexi Liu in Pharmaceutical Research (2016)

  4. No Access

    Article

    Chlorogenic Acid Improves High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice

    Chlorogenic acid (CGA), the most abundant component in coffee, has exhibited many biological activities. The objective of this study is to assess preventive and therapeutic effects of CGA on obesity and obesit...

    Yongjie Ma, Mingming Gao, Dexi Liu in Pharmaceutical Research (2015)

  5. No Access

    Article

    Rutin Suppresses Palmitic Acids-Triggered Inflammation in Macrophages and Blocks High Fat Diet-Induced Obesity and Fatty Liver in Mice

    To elucidate the mechanism of rutin in blocking macrophage-mediated inflammation and high fat diet-induced obesity and fatty liver.

    Mingming Gao, Yongjie Ma, Dexi Liu in Pharmaceutical Research (2013)

  6. No Access

    Article

    Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance

    To examine the effect of farnesoid X receptor (FXR) activation by its synthetic agonist, 3-[2-[2-Chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]benzoic acid (GW4064) on...

    Yongjie Ma, Yixian Huang, Linna Yan, Mingming Gao, Dexi Liu in Pharmaceutical Research (2013)